Abstract 2849: The combination of the PARP inhibitor talazoparib (BMN 673) with the ATR inhibitor VE-821 overcomes the drug resistance of Schlafen 11-deficient cells
Year: 2015
Type: conference-abstract
Source: Cancer Research
Authors: Junko Murai, Yves Pommier
Institutions: Kyoto University, National Institutes of Health
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2231611786